Evidence map›Paper›PMID 38074403›Full record

ArticleRSC advances2023

A thiomorpholine substituted malonyl-coumarin dye for discriminative detection of hydrazine and strong acidity.

Dong-Peng Li, Liangchen Wei, Xinkang Guo, Xin Ran, Tian Zhang, Taohuan Zhang, Haibin Xiao, Wei Shu

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dong-Peng LiSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.
Liangchen WeiSchool of Life Sciences and Medicine, Shandong University of Technology Zibo 255049 P. R. China jdshuwei@163.com.
Xinkang GuoSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.
Xin RanSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.
Tian ZhangSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.ORCID https://orcid.org/0000-0001-9035-1215
Taohuan ZhangSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.
Haibin XiaoSchool of Chemistry and Chemical Engineering, Shandong University of Technology Zibo 255049 P. R. China dpli@sdut.edu.cn haibinxiao@sdut.edu.cn.ORCID https://orcid.org/0000-0001-9368-3733
Wei ShuSchool of Life Sciences and Medicine, Shandong University of Technology Zibo 255049 P. R. China jdshuwei@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection of toxic hydrazine and harmful strong acidity is of great importance for survival of organisms. In the present paper, a new thiomorpholine substituted malonyl-coumarin dye was synthesized for discriminative detection of hydrazine and strong acidity. At pH 7.4, the fluorescence at 560 nm decreased and that at 496 nm increased upon reaction with hydrazine, which was used for on-site detection of hydrazine vapor and endogenous hydrazine in live cells. From pH 2.0 to 1.2, the fluorescence at 563 nm increased greatly, which could be ascribed to the PET process from thiomorpholine to malonyl-coumarin. The probe was desirable for discriminative detection of toxic hydrazine and strong acidity.

Identifiers

PMID38074403
PMCPMC10704299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.